Decisional regret in women receiving high risk or inconclusive prenatal cell-free DNA screening results

References

• Warsof SL, Larion S, Abuhamad AZ. Overview of the impact of noninvasive prenatal testing on diagnostic procedures. Prenat Diagn. 2015;35:972–979.
   PubMed Web of Science ®Google Scholar
• Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–487.
   PubMed Web of Science ®Google Scholar
• Hill M, Taffinder S, Chitty LS, et al. Incremental cost of non-invasive prenatal diagnosis versus invasive prenatal diagnosis of fetal sex in England. Prenat Diagn. 2011;31:267–273.
   PubMed Web of Science ®Google Scholar
• Chiu RW, Chan KC, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA. 2008;105:20458–20463.
   PubMed Web of Science ®Google Scholar
• Norton ME, Brar H, Weiss J, et al. Non-Invasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol. 2012;207:137.e1–137.e8.
   PubMed Web of Science ®Google Scholar
• Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med. 2012;14:296–305.
   PubMed Web of Science ®Google Scholar
• Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ. 2011;342:c7401.
   PubMed Web of Science ®Google Scholar
• Devaney SA, Palomaki GE, Scott JA, et al. Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. JAMA. 2011;306:627–636.
   PubMed Web of Science ®Google Scholar
• Devers PL, Cronister A, Ormond KE, et al. Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the national society of genetic counselors. J Genet Counsel. 2013;22:291–295.
   PubMed Web of Science ®Google Scholar
• Gregg AR, Gross SJ, Best RG, et al. ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med. 2013;15:395–398.
   PubMed Web of Science ®Google Scholar
• Karow J. NIPT continues to take off in 2013 as indications, insurance coverage grow. GenomeWeb [Internet]. 2014 Jan 2. [cited 2018 May 01] Available from: https://www.genomeweb.com/sequencing/nipt-continues-take-2013-indications-insurance-coverage-grow#.Ww6r9S-ZMdV.
   Google Scholar
• Flessel M, Goldman S. California prenatal screening program to include noninvasive testing. ACOG. Org. 2013. https://www.acog.org/About%20ACOG/ACOG%20Departments/District%20Newsletters/District%20IX/September%202013/California%20Prenatal%20Screening%20Program.aspx Last accessed September 2018
   Google Scholar
• Bianchi DW, Parsa S, Bhatt S, et al. Fetal sex chromosome testing by maternal plasma DNA sequencing: Clinical Laboratory experience and biology. Obstet Gynecol. 2015;125:375–382.
   PubMed Web of Science ®Google Scholar
• Porreco RP, Garite TJ, Maurel K, et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol. 2014;211:365.e1–365.12.
   PubMed Web of Science ®Google Scholar
• Zimmermann B, Hill M, Gemelos G, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn. 2012;32:1233–1241.
   PubMed Web of Science ®Google Scholar
• Shipp TD, Shipp DZ, Bromley B, et al. What factors are associated with parents. Birth. 2004;31:272–279.
   PubMed Web of Science ®Google Scholar
• Kooper AJ, Pieters JJ, Eggink AJ, et al. Why do parents prefer to know the fetal sex as part of invasive prenatal testing? ISRN Obstet Gynecol. 2012;2012:1.
   Google Scholar
• Rabinowitz M, Savage M, Pettersen B, et al. Noninvasive cell-free dna-based prenatal detection of microdeletions using single nucleotide polymorphism-targeted sequencing. Obstet Gynecol. 2014;123:167S.
   PubMed Web of Science ®Google Scholar
• Wapner RJ, Babiarz JE, Levy B, et al. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. Am J Obstet Gynecol. 2015;212:332.e1–332.e9.
   Web of Science ®Google Scholar
• Valderramos SG, Rao RR, Scibetta EW, et al. Cell-free DNA screening in clinical practice: abnormal autosomal aneuploidy and microdeletion results. Am J Obstet Gynecol. 2016;215:626.e1–626.e10.
   PubMed Web of Science ®Google Scholar
• Yatsenko SA, Peters DG, Saller DN, et al. Maternal cell-free dna-based screening for fetal microdeletion and the importance of careful diagnostic follow-up. Genet Med. 2015;17:836–838.
   PubMed Web of Science ®Google Scholar
• Dondorp W, de Wert G, Bombard Y, et al. Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet. 2015;23:1438–1450.
   PubMed Web of Science ®Google Scholar
• Gregg AR, Skotko BG, Benkendorf JL, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18:1056–1065.
   PubMed Web of Science ®Google Scholar
• Dar P, Curnow KJ, Gross SJ, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism–based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol. 2014;211:527.e1–527.e17.
   PubMed Web of Science ®Google Scholar
• Ashoor G, Syngelaki A, Poon LC, et al. Fetal fraction in maternal plasma cell-free DNA at 11–13 weeks’ gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol. 2013;41:26–32.
   PubMed Web of Science ®Google Scholar
• Canick JA, Palomaki GE, Kloza EM, et al. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn. 2013;33:667–674.
   PubMed Web of Science ®Google Scholar
• Wang E, Batey A, Struble C, et al. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn. 2013;33:662–666.
   PubMed Web of Science ®Google Scholar
• Gross SJ, Stosic M, McDonald-McGinn DM, et al. Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome. Ultrasound Obstet Gynecol. 2016;47:177–183.
   PubMed Web of Science ®Google Scholar
• Marteau TM, Cook R, Kidd J, et al. The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn. 1992;12:205–214.
   PubMed Web of Science ®Google Scholar
• Marteau TM, Kidd J, Michie S, et al. Anxiety, knowledge and satisfaction in women receiving false positive results on routine prenatal screening: a randomized controlled trial. J Psychosom Obstet Gynecol. 1993;14:185–196.
   PubMed Web of Science ®Google Scholar
• van Schendel RV, Kleinveld JH, Dondorp WJ, et al. Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur J Hum Genet. 2014;22:1345–1350.
   PubMed Web of Science ®Google Scholar
• Allyse M, Sayres LC, Goodspeed T, et al. ‘Don’t want no risk and don’t want no problems’: Public understandings of the risks and benefits of noninvasive prenatal testing in the united states. AJOB Empir Bioeth. 2015;6:5–20.
   PubMedGoogle Scholar
• Lewis C, Hill M, Chitty LS. A qualitative study looking at informed choice in the context of non-invasive prenatal testing for aneuploidy. Prenat Diagn. 2016;36:875–881.
   PubMed Web of Science ®Google Scholar
• Vlemmix F, Warendorf JK, Rosman AN, et al. Decision aids to improve informed decision-making in pregnancy care: a systematic review. BJOG. 2013;120:257–266.
   PubMed Web of Science ®Google Scholar